Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT05056818
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Electronic Health Record Review — OTHERReview of medical records and past imaging examinations
Study Details
This study compares synthetic mammography to full-field digital mammography in image interpretation and performance metrics. Digital breast tomosynthesis (DBT) has previously been found to be superior in performance to standard digital mammography in both screening and diagnostic settings for the early detection and improved diagnosis of breast cancers. DBT in combination with full-field digital mammography (FFDM) reduces recall rates and increases cancer detection rates relative to FFDM alone. Synthetic mammography is a 2-dimensional reconstructed image, using the dataset derived from the DBT acquisition, without requiring additional radiation dose. Collecting information from patients' medical records may help doctors analyze the characteristics, utility, and impact of synthetic mammography to compared to FFDM.
Key Dates
- Start date
- Dec 15, 2020
- Status verified
- Apr 2026
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 750 participants (estimated)
Arms
- Arm: Observational (medical records)Patients' medical records and past imaging examinations are reviewed.
Primary Outcome Measure
To analyze the impact of synthetic mammography (SM), as compared with full-field digital mammography (FFDM [ Time Frame: through study completion, an average of 1 year ]
Central Contacts
- Ray C Mayo, MD713-745-4555
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Ray C. Mayo (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT StudyRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTFPHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple DischargeRecruiting · M.D. Anderson Cancer Center · Houston, Texas